Skip to main content
OpenTrials
Completed

NCT Number: NCT06482736

Effect Of Extracorporeal Shockwave Therapy on Tension-Type Headache in Adolescent Females

Chronic headaches in adolescents can have consequences such as absence from school, inability to maintain social activities, and additional disorders such as anxiety, depression, problems sleeping, and reduced quality of life to investigates the efficacy shock wave diathermy on tension headaches in adolescent females

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tension-type Headache Brain Diseases Central Nervous System Diseases Headache Disorders Headache Disorders, Primary Nervous System Diseases

Age range

15 year–18 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Kerolous Ishak Shehata Kelini

Cairo, Egypt

About this study

The prevalence of headaches increases with age, with a prevalence of 82% during adolescence. Extracorporeal Shockwave Therapy could reduce the pain of myofascial pain syndrome by pain signal alteration, promoting angiogenesis and increasing perfusion in ischemic tissues induced by sensitization of nociceptors and muscle ischemia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Suffering from chronic tension headache (headaches occur 15 or more days a month for at least three months).
  • Their age will range from 15 to 18 years.
  • Having a sedentary lifestyle (A weekly physical activity of < 600 MET-minutes/ week in the international physical activity questionnaire)
  • Having regular menstruation (28 to 34 days).

Exclusion criteria

  • Using oral contraceptives or
  • any hormonal treatment in the previous six months.

Treatment and study plan

Extracorporeal shockwave therapy

Device

Extracorporeal Shockwave Therapy could reduce the pain of myofascial pain syndrome by pain signal alteration, promoting angiogenesis and increasing perfusion in ischemic tissues induced by sensitization of nociceptors and muscle ischemia.

Primary outcomes

  1. digital algometer

    Time frame: The evaluation took place before and after 8 treatment visits using the positional inhibition technique. The treatment was carried out for 4 weeks, 2x a week, lasting 45 to 60 minutes each session.

    Measure pain intensity pre and post treatment which tested the pain points of the muscles: upper trapezius, levator scapula, sternocleidomastoid, splenius head and neck bilaterally.

  2. Electromyography (EMG) for neck muscles

    Time frame: The evaluation took place before and after 8 treatment visits using the positional inhibition technique. The treatment was carried out for 4 weeks, 2x a week, lasting 45 to 60 minutes each session.

    Measure muscle activity pre and post treatmentupper trapezius, levator scapula, sternocleidomastoid, splenius head and neck bilaterally

  3. Headache impact test questionnaire

    Time frame: The treatment was carried out for 4 weeks, 2x a week, lasting 45 to 60 minutes each session.

    The evaluation took place before and after 8 treatment visits using the positional inhibition technique. The treatment was carried out for 4 weeks, 2x a week, lasting 45 to 60 minutes each session.

Sponsors and collaborators

Lead sponsor

October 6 University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
Jul 1, 2024
Registry last updated
Jul 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.